Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Metyrapone bulk supplier for pharma manufacturers

Metyrapone 250 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 250 mg

Reference Brands: Metopirone (USA/EU)

Category: Women's Health

Metyrapone is a cortisol synthesis inhibitor used primarily in diagnostic testing of adrenal function (the metyrapone stimulation test). It works by blocking the enzyme 11‑beta‑hydroxylase in the adrenal gland, reducing cortisol production and allowing clinicians to assess pituitary ACTH reserve. In certain clinical situations, it may also be used to manage endogenous Cushing’s syndrome by lowering cortisol levels. Careful monitoring of hormone levels is required, and side effects can include nausea, dizziness, fatigue, and elevated ACTH.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Metyrapone — third party manufacturing & bulk supply

Metyrapone 250 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Metyrapone is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Metyrapone listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Metyrapone →
Back to Listing

Frequently Asked Questions

Metyrapone is used to assess adrenal gland and pituitary function in hormonal testing (the metyrapone stimulation test) and in some cases to help manage conditions with excessively high cortisol, such as Cushing’s syndrome.

Metyrapone is a synthetic chemical acting as an inhibitor of cortisol synthesis by blocking adrenal 11‑beta‑hydroxylase.

The primary trade name is

Metopirone and generic metyrapone products are manufactured by licensed pharmaceutical companies; exact manufacturer varies by country and market.

The generic name is

The brand name is

Metyrapone is manufactured by pharmaceutical producers in various countries; specific sites depend on regulatory approvals and distribution.

Related Products

Methyltestosterone

Strength:
10 mg

Form: Tablets

Reference Brands: Testred (USA/EU), Methitest (USA/EU)

View Details
Methylergonovine Maleate

Strength:
0.2 mg, 0.2 mg/mL

Form: Tablet / Injection

Reference Brands: Methergine (USA)

View Details
Mifepristone

Strength:
200 mg, 300 mg

Form: Tablets

Reference Brands: Mifeprex (USA), Mifegyne (EU)

View Details
Menotropins

Strength:
75 IU, 150 IU

Form: Injection

Reference Brands: Menopur (USA/EU), Repronex (USA/EU)

View Details
Ibandronic Acid

Strength:
Tablet: 150 mg; Injection: 3mg/3ml

Form: Oral tablet and Intravenous injection

Reference Brands: Boniva® (US & EU); Bondronat®(EU)

View Details
Progesterone Capsule

Strength:
100 mg, 200mg

Form: Capsules

Reference Brands: Prometrium® (US), Utrogestan® (EU)

View Details
Progesterone Vaginal Gel

Strength:
4% and 8%

Form: Vaginal gel

Reference Brands: Crinone® (US & EU)

View Details
Urofollitropin

Strength:
75 IU per vial

Form: Injection

Reference Brands: Fostimon® , Follitrope® (EU); Bravelle®, Follistim®(US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.